Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed May 13, 2016 · 10-Q · 43 days after period end · 0001493152-16-009706
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2012 |
|---|---|---|---|---|
| Net Income | -$12.26M | -$1.64M | -$323.65K | -$1.36K |
| EPS Diluted | -$0.35 | -$0.07 | -$0.03 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 13, 2016 · 43 d after period end
